-
Resignation of Director Bryan Dulhunty and Appendix 3Z
December 14, 2005
We wish to advise that Mr Dulhunty will today resign as a director of Analytica Ltd.
-
Appendix 3Y - Change of Director's Interest
December 14, 2005
-
Appendix 3Y - Change of Director's Interest
December 14, 2005
-
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement
December 09, 2005
-
Berlin-Bremen Stock Exchange - Notification of Inclusion on the Third Market
November 29, 2005
-
Results of the Annual General Meeting
November 24, 2005
The company is pleased to announce that all resolutions put to shareholders at today's Annual General Meeting were passed on a show of hands.
-
Extension of Closing Date of Share Purchase Plan
November 24, 2005
Subsequent to a shareholders question at the Annual General Meeting today, the Board has decided to extend the closing date of the Share Purchase Plan for one week to allow shareholders to review the Chariman's Address and consider their investment in the Company.
-
Chairman's Address to the Annual General Meeting held on 24 November 2005
November 24, 2005
-
Major Shareholding Announcement by Brewer Innovation Fund
November 10, 2005
-
Change of Director's Interest
November 09, 2005
-
Notice of Ceasing to be a Substantial Shareholder
November 09, 2005
-
Appendix 4C - Quarterly Financial Report
October 31, 2005
Appendix 4C Quarterly Financial Report for the quarter ended 30 September 2005.
-
Share Purchase Plan
October 28, 2005
Analytica Limited is offering shareholders the opportunity to participate in a Share Purchase Plan on an equal basis to fund the commercialisation of its syringe technology and Constant Flow Device business, and the new joint venture business in Hong Kong.
-
Notice of Annual General Meeting
October 25, 2005
-
Formation of Joint Venture: Analytica Lingyang Limited
October 21, 2005
Analytica today announced it has reached agreement in principle for the formation of a joint venture to accelerate the international commercialisation of its retractable syringe and constant flow device, while acquiring a range of existing medical devices for the Australian and New Zealand markets.
-
2005 Annual Report
September 20, 2005
-
Change of Director's Interest
September 01, 2005
-
Preliminary Final Report And Full Year Accounts
August 26, 2005
-
Analytica announces addition to its retractable syringe intellectual property
August 24, 2005
Analytica has lodged a provisional patent to protect engineering features designed into its new 3mL retractable syringe. This patent extends the value and protection available to the company from its existing retractable syringe intellectual property. These novel and important modifications are expected to be applied to other syringes in the product line. Prototyping of the 3mL syringe is on schedule for completion by the end of 2005.
-
Expiry Date of Listed Options
August 09, 2005
-
Constant Flow Device (Autoburette) Ready for Commercialisation
August 03, 2005
-
Commitments Test Entity - Fourth Quarter Report
July 27, 2005
-
Change of Address of Place of Business
June 30, 2005
-
Change of Director's Interest
June 30, 2005
-
Notice of Ceasing to be substantial holder
June 30, 2005
-
General Market Update
June 27, 2005
-
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement
June 15, 2005
-
New Retracting Needle Patent
May 10, 2005
Analytica has today lodged a new provisional patent for a retracting needle product. This proposed product provides the safety features of automated needle retraction when used with a conventional disposable syringe or prefilled syringe.
-
Appendix 4C - Quarterly Financial Report
April 28, 2005
Appendix 4C Quarterly Financial Report for the quarter ended 31 March 2005.
-
Resignation of Director Dr Wolf Hanisch and Appendix 3Z
April 21, 2005
Dr Wolf Hanisch has today resigned from the board of Analytica to focus on responsibilities at CBio Limited and BresaGen Limited.
-
Analytica advances its Sharp Smart Retractable Syringe
April 20, 2005
Analytica today successfully completed the production of 500 prototype 5mL Sharp Smart? retractable syringes that have commenced preliminary laboratory testing.
-
Change of Directors Interest
April 08, 2005
-
Change of Directors Interest
April 08, 2005
-
Appendix 3B
March 09, 2005
New issue announcement, application for quotation of additional securities and agreement.
-
Appendix 3Y
March 09, 2005
Change of Director's Interest Notice.
-
Change in Registered Office and Principal Place of Business
March 01, 2005
Analytica Limited has today relocated its business from Castle Hill, NSW to Queensland. The company's offices are now located at: BTP Technology and Conference Centre 1 Clunies Ross Court Eight Mile Plains QLD 4113 Telephone 07 3853 5232 Facsimile 07 3853 5211
-
Appendix 4D Six Months Ended ('current period') 31 December 2004
February 28, 2005
-
Sale of Diagnostics operations
February 24, 2005
Shareholders voted yesterday (23rd February 2005) to approve the sale of the diagnostics division of Analytica Ltd to Vital Diagnostics in accordance with contracts signed on the 23rd December 2004. Under the terms of the sale, Analytica will receive a fixed payment based on asset evaluations and a 7% royalty payment. These payments will be made annually for the next 5 years.
-
Chairman's Address to the General Meeting held on 23 February 2005
February 23, 2005
-
Change of Directors Interest
February 08, 2005
-
Appendix 4C - Quarterly Financial Report
January 28, 2005
Appendix 4C Quarterly Financial Report for the quarter ended 31 December 2004.
-
Change of Directors Interest
January 25, 2005
-
Notice of Extraordinary General Meeting
January 24, 2005
-
Notice of Extraordinary General Meeting - Appointment of Proxy
January 24, 2005
-
Change of Directors Interest
January 10, 2005
-
Appendix 3Y Change of Directors Interest Notice
January 06, 2005
